esmo 2023 highlights: advances in egfr lung cancer second-line therapy
Published 9 months ago • 365 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
0:40
highlights in lung cancer at esmo 2023: papillon and mariposa
-
1:06
lung cancer highlights from esmo 2022
-
4:17
highlights on amivantamab after progression on osimertinib in egfr-mutated nsclc: mariposa-2
-
2:47
esmo clinical practice guidelines: beyond egfr and alk
-
18:29
esmo 2023 lung cancer - chapter 2 highlights – papillon, mariposa, mariposa-2, libretto-431
-
0:58
first line treatment options for activating egfr non-small cell lung cancer | dr. alexander spira
-
6:20
asco 2023 highlights on adjuvant osimertinib in resected egfr mutated nsclc: the adaura trial
-
1:04
esmo 2023 highlights in genitourinary cancer
-
3:44
aacr 2023 highlights on advances in the neoadjuvant treatment of resectable nsclc with john heymach
-
0:56
second line treatment in activating egfr non-small cell lung cancer, mariposa - 2 | onc brothers
-
0:59
new standard of care treatment for egfr exon 20 non-small cell lung cancer | dr. alexander spira
-
0:55
genitourinary cancer highlights at esmo 2023
-
3:23
highlights in gynecological cancers at esmo 2023
-
22:57
jipo round table - esmo 2023 highlights (nsclc)
-
43:11
lung cancer highlights from esmo 2023
-
5:18
expert video report on amivantamab in combination therapy for 1l treatment in egfrm, advanced nsclc
-
3:09
highlights on datopotamab deruxtecan in advanced nsclc: the tropion-lung01 study
-
1:23
highlights from esmo tat 2023 with eliana ruggiero